Speaking (Rapid Review) on Oral Selective Estrogen Receptors Degrader(s) (SERD) at 7th YIR Breast Cancer 2022. Upcoming practice changing class of drugs with exciting original data from Aditya Bardia, MD (what amazing work, take a bow). #breastcancer

Dr. S. Jaishankar Randhir Jaiswal PMO India Sanjay Bhatia

MCG DC Gurugram CMO Haryana TOI Gurgaon This is how millennial city of Gurgaon is progressing. Municipal solid waste being burnt in Sector-47. 6.30 am on 7 May 2022

Smoking causes cancer, 20% of all. Stop smoking! #quitsmoking #NoTobaccoDay Max Institute of Cancer Care

29/F, family completed, IDC Left Breast, T2N1, ER/PR Neg, Her2 FISH Pos, BRCA2 Germ-line Positive with strong fam his, post NACT (TCHP) Question: Should she undergo prophylactic surgery? ISMPO ASCO OncoAlert NationalCancerGrid Max Institute of Cancer Care

Interesting fact from SOFT & TEXT: Tam+OS v/s Tam works much better in Her2+(HR 0.41) as compared to Her2-(HR 0.83) while Exe+OS vs Exe showed similar treatment effect in Her2+ and Her2- #MedTwitter

Molecular Oncology! The way forward.

World Health Day, let's come together and raise awareness about the importance of good health and wellbeing. Join us for an initiative by @imsocial01 @max.healthcare Bhuvan Chugh @cancer_to_life @galleriamarketgurgaon Join us in spreading awareness. #WorldHealthDay

Great time together with #TheLungTeam Excellence in Oncology Care - EIOC #EIOC223 Shaheenah Dawood and great talk by the amazing Sanjay Popat and panel discussion Dr Ullas Batra Vanita Noronha, MBBS MD DM Sandip Patel MD dr nitesh rohatgi Prashant Kumar, CSO & Research Director, KARKINOS Dr (Prof). Vijay Patil Bhuvan Chugh #DrKumarPrabhash #LCSM